Efficacy and safety of subcutaneous golimumab in methotrexate-naïve patients with rheumatoid arthritis: 5-year results of the GO-BEFORE trial.

2016

Evaluate the safety and efficacy of golimumab through 5 years in adults with active RA who had not previously received methotrexate (MTX).

Keywords:

References

Citations